Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients
Annamaria Cattaneo, Clarissa Ferrari, Rudolf Uher, et al.
The International Journal of Neuropsychopharmacology (2016) Vol. 19, Iss. 10, pp. pyw045-pyw045
Open Access | Times Cited: 124

Showing 26-50 of 124 citing articles:

Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Jenessa N. Johnston, Maximillian Greenwald, Ioline D. Henter, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 4, pp. 103518-103518
Open Access | Times Cited: 37
Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study
Luca Sforzini, Annamaria Cattaneo, Clarissa Ferrari, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Impacts of inflammatory cytokines on depression: a cohort study
Fei Liu, Yang Yang, Xiao-Wei Fan, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Role of Glial Cells in Neuronal Function, Mood Disorders, and Drug Addiction
Yousef Tizabi, Bruk Getachew, Sheketha R. Hauser, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 558-558
Open Access | Times Cited: 13
FoxO1, A2M, and TGF-β1: three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses
Annamaria Cattaneo, Nadia Cattane, Chiara Malpighi, et al.
Molecular Psychiatry (2018) Vol. 23, Iss. 11, pp. 2192-2208
Open Access | Times Cited: 78
Small Extracellular Vesicles in Rat Serum Contain Astrocyte-Derived Protein Biomarkers of Repetitive Stress
Cristóbal Gómez-Molina, Mauricio Sandoval, Roberto Henzi, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 3, pp. 232-246
Open Access | Times Cited: 73
Role of Inflammation in Depression and Treatment Implications
Jennifer C. Felger
Handbook of experimental pharmacology (2018), pp. 255-286
Closed Access | Times Cited: 71
Predicting treatment response to antidepressant medication using early changes in emotional processing
Michael Browning, Jonathan Kingslake, Colin T. Dourish, et al.
European Neuropsychopharmacology (2018) Vol. 29, Iss. 1, pp. 66-75
Open Access | Times Cited: 69
Old Friends, immunoregulation, and stress resilience
Dominik Langgartner, Christopher A. Lowry, Stefan O. Reber
Pflügers Archiv - European Journal of Physiology (2018) Vol. 471, Iss. 2, pp. 237-269
Open Access | Times Cited: 65
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni, Dennis J. McCarthy, Bruno Delafont, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 65
The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine
Yu Sun, Wayne C. Drevets, Gustavo Turecki, et al.
Brain Behavior and Immunity (2020) Vol. 87, pp. 404-412
Open Access | Times Cited: 56
Brain-immune crosstalk in the treatment of major depressive disorder
Igor Branchi, S. Poggini, Lucile Capuron, et al.
European Neuropsychopharmacology (2020) Vol. 45, pp. 89-107
Open Access | Times Cited: 56
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial
Michael Browning, Amy C. Bilderbeck, Rebecca Dias, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 7, pp. 1307-1314
Open Access | Times Cited: 45
The role of anxious distress in immune dysregulation in patients with major depressive disorder
Roxanne Gaspersz, Femke Lamers, Gayle Wittenberg, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 12
Open Access | Times Cited: 59
Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder
Stuart Innes, Carmine M. Pariante, Alessandra Borsini
Psychoneuroendocrinology (2018) Vol. 102, pp. 236-247
Open Access | Times Cited: 59
How to measure glucocorticoid receptor’s sensitivity in patients with stress-related psychiatric disorders
Carolin Leistner, Andreas Menke
Psychoneuroendocrinology (2018) Vol. 91, pp. 235-260
Closed Access | Times Cited: 58
Biomarkers for Depression: Recent Insights, Current Challenges and Future Prospects
Rebecca Strawbridge, Allan H. Young, Anthony J. Cleare
FOCUS The Journal of Lifelong Learning in Psychiatry (2018) Vol. 16, Iss. 2, pp. 194-209
Open Access | Times Cited: 58
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
Filippo Caraci, Francesca Calabrese, Raffaella Molteni, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 475-504
Open Access | Times Cited: 57
Lower inflammatory markers in women with antenatal depression brings the M1/M2 balance into focus from a new direction
Åsa Edvinsson, Emma Bränn, Charlotte Hellgren, et al.
Psychoneuroendocrinology (2017) Vol. 80, pp. 15-25
Open Access | Times Cited: 51
Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches
Maria Cristina Petralia, Emanuela Mazzon, Paolo Fagone, et al.
Journal of Affective Disorders (2019) Vol. 263, pp. 15-24
Open Access | Times Cited: 45
Bidirectional association between alopecia areata and major depressive disorder among probands and unaffected siblings: A nationwide population-based study
Ying‐Xiu Dai, Ying‐Hsuan Tai, Chih-Chiang Chen, et al.
Journal of the American Academy of Dermatology (2020) Vol. 82, Iss. 5, pp. 1131-1137
Closed Access | Times Cited: 42
The Effects of Exercise on Anxiety and Depression
Shawn M. Arent, Alan Walker, Michelle A. Arent
(2020), pp. 872-890
Closed Access | Times Cited: 41
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder
Francesco Benedetti, Sara Poletti, Benedetta Vai, et al.
European Neuropsychopharmacology (2020) Vol. 42, pp. 35-44
Closed Access | Times Cited: 40
The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
Melisa Kose, Carmine M. Pariante, Paola Dazzan, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 40
Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
Hyuntae Park, Jongmin Kim, S. Ahn, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5398-5398
Open Access | Times Cited: 36

Scroll to top